Tales froman academic RNAi screening facility; FAQs

Briefings in Functional Genomics

Volumn 10, Issue 4, 2011, Pages 227-237

  Jiang, Ming ^a   Instrell, Rachael ^b   Saunders, Becky ^a   Berven, Haakon ^a   Howell, Michael ^a  

^a High Throughput Screening facility ^*  (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

High throughput screening facility; RNAi; siRNA

Indexed keywords

SMALL INTERFERING RNA;

ARTICLE; BIOINFORMATICS; CAENORHABDITIS ELEGANS; DROSOPHILA; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; REPRODUCIBILITY; RNA INTERFERENCE; RNA SPLICING; SIGNAL TRANSDUCTION; ANIMAL; ARTIFACT; GENETIC TRANSFECTION; METABOLISM; STATISTICS; UNIVERSITY;

ANIMALS; ARTIFACTS; GENETIC TESTING; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STATISTICS AS TOPIC; TRANSFECTION; UNIVERSITIES;

EID: 80051888250     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elr016     Document Type: Article

References (100)

1. Falschlehner C, Steinbrink S, Erdmann G, et al. Highthroughput RNAi screening to dissect cellular pathways: a how-to guide. BiotechnolJ 2010;5:368-76.
2. Lord CJ, Martin SA, Ashworth A. RNA interference screening demystified. J Clin Pathol 2009;62:195-200.
3. Echeverri CJ, Perrimon N. High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet 2006;7:373-84.
4. Mohr S, Bakal C, Perrimon N. Genomic screening with RNAi: results and challenges. Annu Rev Biochem 2010;79: 37-64.
5. Sachse C, Krausz E, Kronke A, et al. High-throughput RNA interference strategies for target discovery and validation by using synthetic short interfering RNAs: functional genomics investigations of biological pathways. Methods Enzymol 2005;392:242-77.
6. Erfle H, Neumann B, Liebel U, et al. Reverse transfection on cell arrays for high content screening microscopy. Nat Protoc 2007;2:392-9.
7. Erfle H, Neumann B, Rogers P, et al. Work flow for multiplexing siRNA assays by solid-phase reverse transfection in multiwell plates. J Biomol Screen 2008;13:575-80.
8. Boutros M, Ahringer J. The art and design of genetic screens: RNA interference. Nat Rev Genet 2008;9:554-66.
9. Carralot JP, Kim TK, Lenseigne B, et al. Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. J Biomol Screen 2009;14:151-60.
10. Boese Q, Leake D, Reynolds A, et al. Mechanistic insights aid computational short interfering RNA design. Methods Enzymol 2005;392:73-96.
11. Abdelrahim M, Safe S, Baker C, et al. RNAi and cancer: Implications and applications. JRNAi Gene Silencing 2006;2: 136-45.
12. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009;10:94-108.
13. Sharp PA. The centrality of RNA. Cell 2009;136:577-80.
14. van den Berg BH, McCarthy FM, Lamont SJ, et al. Re-annotation is an essential step in systems biology modeling of functional genomics data. PLoS One 2010;5: e10642.
15. Neumann B, Walter T, Heriche JK, et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010;464:721-7.
16. Kittler R, Surendranath V, Heninger A-K, et al. Genomewide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies. Nat Meth 2007;4:337-44.
17. Fedorov Y, King A, Anderson E, et al. Different delivery methods-different expression profiles. Nat Methods 2005;2: 241.
18. Portis AM, Carballo G, Baker GL, et al. Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles. Micros Res Techniq 2010;73:878-85.
19. Bauer M, Kristensen BW, Meyer M, et al. Toxic effects of lipidmediated gene transfer in ventral mesencephalic explant cultures. Basic Clin Pharmacol Toxicol 2006;98:395-400.
20. Spagnou S, Miller AD, Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 2004;43:13348-56.
21. Zumbansen M, Altrogge LM, Spottke NU, et al. First siRNA library screening in hard-to-transfect HUVEC cells. JRNAi Gene Silencing 2010;6:354-60.
22. Maurisse R, De Semir D, Emamekhoo H, et al. Comparative transfection of DNA into primary and transformed mammalian cells from different lineages. BMC Biotechnol 2010;10:9.
23. Brazas RM, Hagstrom JE. Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents. Methods Enzymol 2005;392:112-24.
24. Mocellin S, Provenzano M. RNA interference: learning gene knock-down from cell physiology. JTranslMed 2004; 2:39.
25. Altschuler SJ, Wu LF. Cellular heterogeneity: do differences make a difference? Cell 2010;141:559-63.
26. Eldar A, Elowitz MB. Functional roles for noise in genetic circuits. Nature 2010;467:167-73.
27. Levsky JM, Singer RH. Gene expression and the myth of the average cell. Trends Cell Biol 2003;13:4-6.
28. Sacher R, Stergiou L, Pelkmans L. Lessons from genetics: interpreting complex phenotypes in RNAi screens. Curr Opin Cell Biol 2008;20:483-9.
29. Yuan TL, Wulf G, Burga L, Cantley LC. Cell-to-cell variability in PI3K protein level regulates PI3K-AKT pathway activity in cell populations. Curr Biol 2011;21:173-83.
30. Snijder B, Pelkmans L. Origins of regulated cell-to-cell variability. Nat RevMol Cell Biol 2011;12:119-25.
31. Swearingen EA, Fajardo F, Wang X, et al. Use of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA libraries. J Biomol Screen 2010;15: 469-77.
32. Lundholt BK, Scudder KM, Pagliaro L. A Simple technique for reducing edge effect in cell-based assays. J Biomol Screen 2003;8:566-70.
33. Cooke SL, Temple J, MacArthur S, et al. Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer. Br J Cancer 2011;104:361-8.
34. Gerlinger M, Swanton C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer 2010;103:1139-43.
35. Navin N, Krasnitz A, Rodgers L, et al. Inferring tumor progression from genomic heterogeneity. Genome Res 2010;20:68-80.
36. Manning BD. Challenges and opportunities in defining the essential cancer kinome. Sci Signal 2009;2:pe15.
37. Conrad C, Gerlich DW. Automated microscopy for high-content RNAi screening. J Cell Biol 2010;188: 453-61.
38. Bjorklund M, Taipale M, Varjosalo M, et al. Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature 2006;439:1009-13.
39. Carpenter AE, Sabatini DM. Systematic genome-wide screens of gene function. Nat Rev Genet 2004;5:11-22.
40. Perlman ZE, Slack MD, Feng Y, et al. Multidimensional drug profiling by automated microscopy. Science 2004;306: 1194-8.
41. Tsui M, Xie T, Orth JD, et al. An intermittent live cell imaging screen for siRNA enhancers and suppressors of a Kinesin-5 inhibitor. PLoS One 2009;4:e7339.
42. Gascoigne KE, Taylor SS. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 2008;14:111-22.
43. Slack MD, Martinez ED, Wu LF, et al. Characterizing heterogeneous cellular responses to perturbations. Proc Natl Acad SciUSA 2008;105:19306-11.
44. Bramsen JB, Pakula MM, Hansen TB, et al. A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects. Nucleic Acids Res 2010;38:5761-73.
45. Iorns E, Lord CJ, Turner N, et al. Utilizing RNA interference to enhance cancer drug discovery. Nat Rev Drug Discov 2007;6:556-68.
46. Birmingham A, Selfors LM, Forster T, etal. Statistical methods for analysis of high-throughput RNA interference screens. Nat Meth 2009;6:569-75.
47. Boutros M, Bras LP, Huber W. Analysis of cell-based RNAi screens. Genome Biol 2006;7:R66.
48. Malo N, Hanley JA, Cerquozzi S, et al. Statistical practice in high-throughput screening data analysis. Nat Biotechnol 2006;24:167-75.
49. Pelz O, Gilsdorf M, Boutros M. Web cellHTS2: a web-application for the analysis of high-throughput screening data. BMC Bioinformatics 2010;11:185.
50. Chung N, Zhang XD, Kreamer A, et al. Median absolute deviation to improve hit selection for genome-scale RNAi screens. J Biomol Screen 2008;13:149-58.
51. Zhang XD. An effective method for controlling false discovery and false nondiscovery rates in genome-scale RNAi screens. J Biomol Screen 2010;15:1116-22.
52. Zhang XD, Heyse JF. Determination of sample size in genome-scale RNAi screens. Bioinformatics 2009;25:841-4.
53. Zhang XD, Lacson R, Yang R, et al. The use of SSMD-based false discovery and false nondiscovery rates in genome-scale RNAi screens. J Biomol Screen 2010;15: 1123-31.
54. Chatterjee S, Firat A. Generating data with identical statistics but dissimilar graphics. Am Stat 2007;61:248-254.
55. Barrows NJ, Sommer CL, Garcia-Blanco MA, et al. Factors affecting reproducibility between genome-scale siRNA-based screens. J Biomol Screen 2010;15:735-47.
56. Bankhead A, 3rd, Sach I, Ni C, et al. Knowledge based identification of essential signaling from genome-scale siRNA experiments. BMCSyst Biol 2009;3:80.
57. Wiles AM, Ravi D, Bhavani S, et al. An analysis of normalization methods for Drosophila RNAi genomic screens and development of a robust validation scheme. J Biomol Screen 2008;13:777-84.
58. Kittler R, Pelletier L, Ma C, et al. RNA interference rescue by bacterial artificial chromosome transgenesis in mammalian tissue culture cells. Proc Natl Acad Sci USA 2005;102: 2396-401.
59. Kittler R, Pelletier L, Heninger A-K, et al. Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat Cell Biol 2007;9:1401-12.
60. Parsons BD, Schindler A, Evans DH, et al. A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay. PLoS One 2009;4:e8471.
61. Martin SE, Jones TL, Thomas CL, et al. Multiplexing siRNAs to compress RNAi-based screen size in human cells. Nucleic Acids Res 2007;35:e57.
62. Fedorov Y, Anderson EM, Birmingham A, et al. Off-target effects by siRNA can induce toxic phenotype. RNA 2006; 12:1188-96.
63. Jackson AL, Burchard J, Schelter J, et al. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA 2006;12:1179-87.
64. Klinghoffer RA, Magnus J, Schelter J, et al. Reduced seed region-based off-target activity with lentivirus-mediated RNAi. RNA 2010;16:879-84.
65. Kulkarni MM, Booker M, Silver SJ, et al. Evidence of off-target effects associated with long dsRNAs in Drosophila melanogaster cell-based assays. Nat Meth 2006; 3:833-8.
66. Sudbery I, Enright A, Fraser A, et al. Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis. BMC Genomics 2010;11:175.
67. Aleman LM, Doench J, Sharp PA. Comparison of siRNA-induced off-target RNA and protein effects. RNA 2007;13:385-95.
68. MacDonald ML, Lamerdin J, Owens S, et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2006;2:329-37.
69. Ribeiro PS, JosuE' F, Wepf A, et al. Combined functional genomic and proteomic approaches identify a PP2A complex as a negative regulator of hippo signaling. Mol Cell 2010;39:521-34.
70. DasGupta R, Nybakken K, Booker M, et al. A case study of the reproducibility of transcriptional reporter cell-based RNAi screens in Drosophila. Genome Biol 2007;8:R203.
71. Cherry S. What have RNAi screens taught us about viral-host interactions? Curr OpinMicrobiol 2009;12:446-52.
72. Hirsch AJ. The use of RNAi-based screens to identify host proteins involved in viral replication. FutureMicrobiol 2010; 5:303-11.
73. Muller P, Boutros M, Zeidler MP. Identification of JAK/STAT pathway regulators-insights from RNAi screens. Semin CellDev Biol 2008;19:360-9.
74. Liu T, Sims D, Baum B. Parallel RNAi screens across different cell lines identify generic and cell type-specific regulators of actin organization and cell morphology. Genome Biol 2009;10:R26.
75. Valanne S, Myllymaki H, Kallio J, et al. Genome-wide RNA interference in Drosophila cells identifies G protein-coupled receptor kinase 2 as a conserved regulator of NF-kappaB signaling. J Immunol 2010;184:6188-98.
76. Saj A, Arziman Z, Stempfle D, et al. A combined ex vivo and in vivo RNAi screen for notch regulators in Drosophila reveals an extensive notch interaction network. Dev Cell 2010;18:862-76.
77. Mourikis P, Lake RJ, Firnhaber CB, et al. Modifiers of notch transcriptional activity identified by genome-wide RNAi. BMCDev Biol 2010;10:107.
78. Kockel L, Kerr KS, Melnick M, et al. Dynamic switch of negative feedback regulation in Drosophila Akt-TOR signaling. PLoS Genet 2010;6:e1000990.
79. Kallio J, Myllymaki H, Gronholm J, et al. Eye transformer is a negative regulator of Drosophila JAK/STAT signaling. FASEB J 2010;24:4467-79.
80. Dekanty A, Romero NM, Bertolin AP, et al. Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia. PLoS Genet 2010;6:e1000994.
81. Leber B, Maier B, Fuchs F, et al. Proteins required for centrosome clustering in cancer cells. Sci Transl Med 2010; 2:33ra38.
82. Schmitz MH, Held M, Janssens V, et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol 2010;12:886-93.
83. Moore MJ, Wang Q, Kennedy CJ, et al. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010;142:625-36.
84. Ashton-Beaucage D, Udell CM, Lavoie H, et al. The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila. Cell 2010; 143:251-62.
85. D'Ambrosio MV, Vale RD. A whole genome RNAi screen of Drosophila S2 cell spreading performed using automated computational image analysis. J Cell Biol 2010; 191:471-8.
86. Wang Q, Silver PA. Genome-wide RNAi screen discovers functional coupling of alternative splicing and cell cycle control to apoptosis regulation. Cell Cycle 2010;9:4419-21.
87. Lipinski MM, Hoffman G, Ng A, et al. A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell 2010;18:1041-52.
88. Wendler F, Gillingham AK, Sinka R, et al. A genome-wide RNA interference screen identifies two novel components of the metazoan secretory pathway. EMBO J 2010;29: 304-14.
89. Kuttenkeuler D, Pelte N, Ragab A, et al. A large-scale RNAi screen identifies Deaf1 as a regulator of innate immune responses in Drosophila. J Innate Immun 2010;2: 181-94.
90. Chia NY, Chan YS, Feng B, et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 2010;468:316-20.
91. Akimana C, Al-Khodor S, Abu Kwaik Y. Host factors required for modulation of phagosome biogenesis and proliferation of Francisella tularensis within the cytosol. PLoS One 2010;5:e11025.
92. Moser TS, Sabin LR, Cherry S. RNAi screening for host factors involved in Vaccinia virus infection using Drosophila cells. JVis Exp 2010;42:2137.
93. Smith JA, White EA, Sowa ME, et al. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci USA 2010;107:3752-7.
94. Karlas A, Machuy N, Shin Y, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010;463:818-22.
95. Kumar D, Nath L, Kamal MA, et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 2010;140:731-43.
96. Sudo H, Tsuji AB, Sugyo A, et al. Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model. Genomics 2010;95:210-16.
97. Chen S, Blank JL, Peters T, et al. Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib. Cancer Res 2010;70:4318-26.
98. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009;23:1494-504.
99. Faghihi MA, Kocerha J, Modarresi F, et al. RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS One 2010;5:e13177.
100. Haney SA. Increasing the robustness and validity of RNAi screens. Pharmacogenomics 2007;8:1037-49.